Franklin, K.B.J. & Paxinos, G. (1997) The Mouse Brain in Stereotaxic
Coordinates. Academic Press, London.
Gale, K. (1992) Subcortical structures and pathways involved in convulsive
seizure generation. J. Clin. Neurophysiol., 9, 264–277.
Gray, J.A. (1987) The neuropsychology of anxiety. An Enquiry in to the
Functions of the Septohippocampal System. Oxford Science Publications,
Oxford.
Green, S. & Vale, A.L. (1992) Role of amygdaloid nuclei in the anxiolytic
effects of benzodiazepines in rats. Behav. Pharmacol., 3, 261–264.
Hodges, H., Green, S. & Glenn, B. (1987) Evidence that the amygdala is
involved in benzodiazepine and serotonergic effects on punished responding
but not on discrimination. Psychopharmacology, 92, 491–504.
Izzo, E., Anta, J., Impagnatiello, F., Pesold, C., Guidotti, A. & Costa, E. (2001)
Glutamic acid decarboxylase and glutamate receptor changes during
tolerance and dependence to benzodiazepines. Proc. Natl Acad. Sci.
U.S.A., 98, 3483–3488.
Karcz-Kubicha, M. & Liljequist, S. (1995) Evidence for an anxiogenic action
of AMPA receptor antagonists in the plus-maze test. Eur. J. Pharmacol., 279,
171–177.
Kodama, M., Yamada, N., Sato, K., Kitamura, Y., Koyama, F., Sato, T.,
Morimoto, K. & Kuroda, S. (1999) Effects of YM90K, a selective AMPA
receptor antagonist, on amygdala-kindling and long-term hippocampal
potentiation in the rat. Eur. J. Pharmacol., 374, 11–19.
Kotlinska, J. & Liljequist, S. (1998) The putative AMPA receptor antagonist,
LY326325, produces anxiolytic-like effects without altering locomotor
activity in rats. Pharmacol. Biochem. Behav., 60, 119–124.
Kraus, J.E., Yeh, G.C., Bonhaus, D.W., Nadler, J.V. & McNamara, J.O.
(1994) Kindling induces the long-lasting expression of a novel population
of NMDA receptors in hippocampal region CA3. J. Neurosci., 14,
196–205.
LeDoux, J. (1998) Fear and the brain: where have we been, and where are we
going? Biol. Psychiat., 44, 1229–1238.
Lissin, D.V., Gomperts, S.N., Carroll, R.C., Christine, C.W., Kalman, D.,
Kitamura, M., Hardy, S., Nicoll, R.A., Malenka, R.C. & Von Zastrow, M.
(1998) Activity differentially regulates the surface expression of synaptic
AMPA and NMDA receptors. Proc. Natl Acad. Sci. U.S.A., 95, 7097–
7102.
Lothman, E.W., Hatlelid, J.M. & Zorumski, C.F. (1985) Functional mapping of
limbic seizures originating in the hippocampus: a combined 2-deoxyglucose
and electrophysiologic study. Brain Res., 360, 92–100.
Maddock, R.J. (1999) The retrosplenial cortex and emotion; new insights
from functional neuroimaging of the human brain. Trends Neurosci., 22,
310–316.
Mesches, M.H., Bianchin, M. & McGaugh, J.L. (1996) The effects of intraamygdala infusion of the AMPA receptor antagonist CNQX on retention
performance following aversive training. Neurobiol. Learn. Mem., 66, 324–
340.
Mody, I. & Heinemann, U. (1987) NMDA receptors of dentate gyrus granule
cells participate in synaptic transmission following kindling. Nature, 326,
701–704.
Monaghan, D.T., Yao, D. & Cotman, C.W. (1984) Distribution of [3H]AMPA
binding sites in rat brain as determined by quantitative autoradiography.
Brain Res., 324, 160–164.
Mutel, V., Trube, G., Klingelschmidt, A., Messer, J., Bleuel, Z. et al. (1998)
Binding characteristics of a potent AMPA receptor antagonist [3H]Ro48
8587 in rat brain. J. Neurochem., 71, 418–426.
Nadler, J.V., Thompson, M.A. & McNamara, J.O. (1994) Kindling reduces
sensitivity of CA3 hippocampal pyramidal cells to competitive NMDA
receptor antagonists. Neuropharmacology, 33, 147–153.
Namba, T., Morimoto, K., Sato, K., Yamada, N. & Kuroda, S. (1994)
Antiepileptogenic and anticonvulsant effects of NBQX, a selective AMPA
receptor antagonist, in the rat kindling model of epilepsy. Brain Res., 638,
36–44.
Nielsen, E.O., Cha, J.H., Honore, T., Penney, J.B. & Young, A.B. (1988)
Thiocyanate stabilizes AMPA binding to the quisqualate receptor. Eur. J.
Pharmacol., 157, 197–203.
Nielsen, E.O., Drejer, J., Cha, J.-H.J., Young, A.B. & Honore, T. (1990)
Autoradiographic characterisation and localisation of quisqualate binding
sites in rat brain using the antagonist [3H]-cyano-7-nitroquinoxaline-2,3-
